Literature DB >> 15851655

Recruiting dendritic cells to improve antibody therapy of cancer.

Kavita M Dhodapkar1, Madhav V Dhodapkar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15851655      PMCID： PMC1088395          DOI： 10.1073/pnas.0502547102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

Review 1.  The evolution of antibodies into versatile tumor-targeting agents.

Authors:  Michael Z Lin; Michael A Teitell; Gary J Schiller
Journal:  Clin Cancer Res       Date:  2005-01-01       Impact factor: 12.531

2.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Authors:  Veronika Groh; Jennifer Wu; Cassian Yee; Thomas Spies
Journal:  Nature       Date:  2002-10-17       Impact factor: 49.962

3.  Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells.

Authors:  Kavita M Dhodapkar; Jacob L Kaufman; Marc Ehlers; Devi K Banerjee; Ezio Bonvini; Scott Koenig; Ralph M Steinman; Jeffrey V Ravetch; Madhav V Dhodapkar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-09       Impact factor: 11.205

4.  T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells.

Authors:  Madhav V Dhodapkar; Joseph Krasovsky; Kara Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

5.  Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma.

Authors:  Wen-Kai Weng; Ronald Levy
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

6.  Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells.

Authors:  Kenichi Akiyama; Shin Ebihara; Ayumi Yada; Kimio Matsumura; Setsuya Aiba; Toshihiro Nukiwa; Toshiyuki Takai
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

Review 7.  Cancer immunotherapy: a treatment for the masses.

Authors:  Joseph N Blattman; Philip D Greenberg
Journal:  Science       Date:  2004-07-09       Impact factor: 47.728

8.  Fc gamma receptors and cross-presentation in dendritic cells.

Authors:  Sebastian Amigorena
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

9.  Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.

Authors:  A Regnault; D Lankar; V Lacabanne; A Rodriguez; C Théry; M Rescigno; T Saito; S Verbeek; C Bonnerot; P Ricciardi-Castagnoli; S Amigorena
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells.

Authors:  Alexis M Kalergis; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307
View more
  20 in total

Review 1.  Role of chaperones and FcgammaR in immunogenic death.

Authors:  Madhav V Dhodapkar; Kavita M Dhodapkar; Zihai Li
Journal:  Curr Opin Immunol       Date:  2008-06-21       Impact factor: 7.486

2.  In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cells.

Authors:  Archana Thakur; Oxana Norkina; Lawrence G Lum
Journal:  Cancer Immunol Immunother       Date:  2011-06-29       Impact factor: 6.968

3.  Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo.

Authors:  Suzanne N Franki; Kristopher K Steward; David J Betting; Kamran Kafi; Reiko E Yamada; John M Timmerman
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

4.  Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas.

Authors:  Kham R Trinh; Alex Vasuthasawat; Kristopher K Steward; Reiko E Yamada; John M Timmerman; Sherie L Morrison
Journal:  J Immunother       Date:  2013-06       Impact factor: 4.456

Review 5.  Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens.

Authors:  Danuta Kozbor
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

6.  Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.

Authors:  Kobporn Boonnak; Bonnie M Slike; Timothy H Burgess; Randall M Mason; Shuenn-Jue Wu; Peifang Sun; Kevin Porter; Irani Fianza Rudiman; Djoko Yuwono; Pilaipan Puthavathana; Mary A Marovich
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

7.  Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.

Authors:  Margaret Gil; Magdalena Bieniasz; Andrzej Wierzbicki; Barbara J Bambach; Hanna Rokita; Danuta Kozbor
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

8.  Endogenous cytotoxic T-cell response contributes to the long-term antiretroviral protection induced by a short period of antibody-based immunotherapy of neonatally infected mice.

Authors:  Laurent Gros; Mireia Pelegrin; Henri-Alexandre Michaud; Stéphanie Bianco; Javier Hernandez; Chantal Jacquet; Marc Piechaczyk
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 9.  Interactions of tumor cells with dendritic cells: balancing immunity and tolerance.

Authors:  M V Dhodapkar; K M Dhodapkar; A K Palucka
Journal:  Cell Death Differ       Date:  2007-10-19       Impact factor: 15.828

10.  Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.

Authors:  Masahisa Jinushi; Marimo Sato; Akira Kanamoto; Akihiko Itoh; Shigenori Nagai; Shigeo Koyasu; Glenn Dranoff; Hideaki Tahara
Journal:  J Exp Med       Date:  2009-05-11       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.